Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-3326-2026

Pipeline Flex Embolization Device with Shield Technology REF PED2-300-12 UDI-DI code: 00763000448806 he Pipeline Flex Embolization Device with Shield Technology consists of a permanent implant combined with a guidewire based delivery system. The Pipeline Flex Embolization Device with Shield Technology implant is a braided, multi-alloy, mesh cylinder woven from platinum/tungsten and cobalt-chromium-nickel alloy wires and indicated for the endovascular treatment of adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments.

Publicado el 7 de octubre de 2026 · Inicio del retiro: 25 de junio de 2026

Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

Due to incorrect label/product dimensions. Product is supposed to be 3.00 mm in diameter, but unit is packaging was a 2.50 mm in diameter.

Qué hacer

Voluntary: Firm initiated · Letter

Detalles del retiro

Fabricante
Micro Therapeutics, Inc.
Distribuidor
U.S. Nationwide distribution in the states of GA and TX.
Lote
Product/Catalog Number: PED2-300-12 UDI-DI/GTIN: 00763000448806 Lot Number: #D112860
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Pipeline Flex Embolization Device with Shield Technology REF PED2-300-12 UDI-DI code: 00763000448806 he Pipeline Flex Embolization Device with Shield Technology consists of a permanent implant combined with a guidewire based delivery system. The Pipeline Flex Embolization Device with Shield Technology implant is a braided, multi-alloy, mesh cylinder woven from platinum/tungsten and cobalt-chromium-nickel alloy wires and indicated for the endovascular treatment of adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments. fue retirado del mercado?

Sí. FDA publicó el retiro Z-3326-2026 el 7 de octubre de 2026. Peligro reportado: Due to incorrect label/product dimensions. Product is supposed to be 3.00 mm in diameter, but unit is packaging was a 2.50 mm in diameter.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter

¿Vendes productos como este?

Recalert vigila todo tu catálogo contra retiros como este, automáticamente.

Recalert también vigila fechas de caducidad para que vendas el inventario antes de que se convierta en pérdida.

Revisa tu inventario (gratis)